Global Veterinary Vaccination Market Growth (Status and Outlook) 2025-2031

The global Veterinary Vaccination market size is predicted to grow from US$ 12730 million in 2025 to US$ 19280 million in 2031; it is expected to grow at a CAGR of 7.2% from 2025 to 2031.

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.

The veterinary vaccination market is driven by the increasing awareness of animal health and the growing demand for preventive measures against infectious diseases in animals. Veterinary vaccinations play a crucial role in protecting animals from a wide range of infectious diseases, improving animal welfare, and preventing disease transmission to humans. The rise in pet ownership and the intensification of livestock production contribute to market growth as animal owners and farmers prioritize vaccination as a preventive healthcare measure. Moreover, advancements in vaccine technology, such as the development of recombinant and vectored vaccines, have improved vaccine efficacy and safety for diverse animal species. However, the market also faces challenges, including the need for tailored vaccination programs for different animal populations and the ongoing threat of emerging and evolving pathogens. Additionally, addressing vaccine hesitancy among animal owners and the cost of vaccination in low-income regions can pose obstacles for comprehensive animal health protection. To succeed, companies must focus on research and development to offer innovative and targeted veterinary vaccines, collaborate with veterinary professionals to promote vaccination education, and address the challenges to meet the increasing demand for effective and accessible animal health solutions.

LPI (LP Information)' newest research report, the “Veterinary Vaccination Industry Forecast” looks at past sales and reviews total world Veterinary Vaccination sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Vaccination sales for 2025 through 2031. With Veterinary Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Vaccination industry.

This Insight Report provides a comprehensive analysis of the global Veterinary Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Veterinary Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Vaccination market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Vaccination and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Vaccination.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Vaccination market by product type, application, key players and key regions and countries.

Segmentation by Type:
Live Attenuated Vaccines
Inactivated Vaccines
Other

Segmentation by Application:
Livestock
Swine
Chicken
Dog & Cat
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health

Please note: The report will take approximately 2 business days to prepare and deliver.